| Product NDC: | 65841-626 |
| Proprietary Name: | Haloperidol |
| Non Proprietary Name: | Haloperidol |
| Active Ingredient(s): | 5 mg/1 & nbsp; Haloperidol |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 65841-626 |
| Labeler Name: | Cadila Healthcare Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077580 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080103 |
| Package NDC: | 65841-626-10 |
| Package Description: | 1000 TABLET in 1 BOTTLE (65841-626-10) |
| NDC Code | 65841-626-10 |
| Proprietary Name | Haloperidol |
| Package Description | 1000 TABLET in 1 BOTTLE (65841-626-10) |
| Product NDC | 65841-626 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Haloperidol |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20080103 |
| Marketing Category Name | ANDA |
| Labeler Name | Cadila Healthcare Limited |
| Substance Name | HALOPERIDOL |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Typical Antipsychotic [EPC] |